<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cunningham, Muriel</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Hill, Michael D.</style></author><author><style face="normal" font="default" size="100%">Goyal, Mayank</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The ESCAPE Trial: Rapid Endovascular Treatment Leads to Better Outcomes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-10</style></pages><abstract><style  face="normal" font="default" size="100%">ESCAPE was a phase 3, multicenter, prospective, randomized, open-label, controlled trial conducted in patients with acute ischemic stroke. Patients received rapid, modern endovascular treatment plus guideline-based care (intervention) or guideline-based care alone. Patients in the intervention group had greater benefits in mortality, morbidity, and quality of life compared with controls.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>